Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics

Sarepta Therapeutics, Inc. (SRPT)

Today's Latest Price: $127.90 USD

2.40 (-1.84%)

Updated Jan 17 12:00am

Add SRPT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all "A" rated Strong Buy stocks

SRPT Stock Summary

  • Of note is the ratio of Sarepta Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 14.94% of US stocks have a lower such ratio.
  • With a price/sales ratio of 26.59, Sarepta Therapeutics Inc has a higher such ratio than 95.26% of stocks in our set.
  • Over the past twelve months, SRPT has reported earnings growth of 170.12%, putting it ahead of 93% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Sarepta Therapeutics Inc are PTCT, OMEX, MTEM, PGNX, and DNN.
  • Visit SRPT's SEC page to see the company's official filings. To visit the company's web site, go to
SRPT Daily Price Range
SRPT 52-Week Price Range

SRPT Stock Price Chart More Charts

SRPT Price/Volume Stats

Current price $127.90 52-week high $158.80
Prev. close $130.30 52-week low $72.05
Day low $127.44 Volume 862,500
Day high $131.24 Avg. volume 967,067
50-day MA $116.12 Dividend yield N/A
200-day MA $114.32 Market Cap 9.53B

Sarepta Therapeutics, Inc. (SRPT) Company Bio

Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.

SRPT Latest News Stream

Event/Time News Detail
Loading, please wait...

SRPT Latest Social Stream

Loading social stream, please wait...

View Full SRPT Social Stream

SRPT Price Returns

1-mo 2.07%
3-mo 49.12%
6-mo -11.62%
1-year 4.15%
3-year 255.48%
5-year 956.15%
YTD -0.88%
2019 18.24%
2018 96.14%
2017 102.84%
2016 -28.90%
2015 166.62%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5296 seconds.